REFERENCES
- Zeng X., Martin G., Marriott C. The controlled delivery of drugs to the lung. Int. J. Pharm. 1995; 124: 149–164
- Byron P. Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation. J. Pharm. Sci. 1986; 75: 433–438
- Gonda I. Drugs administered directly into the respiratory tract: modelling of the duration of effective drug levels. J. Pharm. Sci. 1988; 77: 341–346
- Farr S. J., Kellaway I., Parry-Jones D., Woolfrey S. 99m-Technetium as a marker of liposomal deposition and clearance in the human lung. Int. J. Pharm. 1985; 26: 303–316
- Edwards D., Chen D., Wang J., Ben-Jebria A. Controlled-release inhalation aerosols. Respiratory Drug Delivery VI, P. R. Byron, R. N. Dalby, S. J. Farr. Interpharm Press, Buffalo GroveIL 1998; 187–192
- British Pharmacopoeia. HMSO, London 1998
- European Pharmacopoeia. 3rd ed., Strasbourg, France 1996
- U.S. Pharmacopeial Convention. United States Pharmacopoeia 1995. Author, Rockville, MD 1994
- Burnell P., Grant A., Haywood P., Prime D., Sumby B. Powder inhalers—exploring the limits of performance. Respiratory Drug Delivery VI, P. R. Byron, R. N. Dalby, S. J. Farr. Interpharm Press, Buffalo Grove, IL 1998; 259–266
- Zeng X., Martin G., Marriott C. Preparation and in vitro evaluation of tetrandrine-entrapped albumin microspheres as an inhaled drug delivery system. Eur. J. Pharm. Sci. 1995; 3: 87–93
- Dalby R. N., Byron P. R. Sustained release of terbutaline sulfate aerosols, Interphex USA Proceedings. 1988; 21–45
- Challinor C. L. Characterisation and manipulation of controlled drug release using a heterodisperse polysaccharide matrix, Ph.D. thesis. University of Bath, United Kingdom 1996
- Hallworth G., Clough D., Newham T., Andrews U. A simple impinger device for rapid quality control of the particle size of inhalation aerosols delivered by pressurised aerosols and powder inhalers. J. Pharm. Pharmacol. 1978; 30: 39P
- El-Baseir M., Kellaway I. Poly(l-lactic acid) microspheres for pulmonary delivery: release kinetics and aerosolisation studies. Int. J. Pharm. 1998; 75: 135–145
- Timsina M., Martin G., Marriott C., Ganderton D., Yianneskis M. Drug delivery to the respiratory tract using dry powder inhalers. Int. J. Pharm. 1994; 101: 1–13
- Ruffin R., Dolovich M., Oldenburg F., Newhouse M. The preferential deposition of isoproterenol and propranolol in asthmatic patients. Chest 1977; 80: 904–907
- Niven R. Modulated drug therapy with inhalation aerosols. Pharmaceutical Inhalation Aerosol Technology, A. J. Hickey. Marcel Dekker, New York 1992; 21–359
- Weibel E. R. Morphometry of the Human Lung. Springer-Verlag OHG, Berlin 1963; 110–143
- Corbo M., Schultz W., Wong G., Van Buskirk G. Development and validation of in vitro release testing methods for semisolid formulations. Pharm. Tech. 1993; 9: 112–128
- Fitzpatrick J. Xanthan gum in hydrophilic matrix delivery systems. Excipients and Delivery Systems for Pharmaceutical Formulations, D. Karsa, R. Stephenson. Royal Society of Chemistry, LondonUK 1995; 123–132
- Dhopeshwarkar V., Zatz J. Evaluation of xanthan gum in the preparation of sustained release matrix tablets. Drug Dev. Ind. Pharm. 1993; 19: 999–1017
- Rol F. Locust bean gum. Industrial Gums. Polysaccharides and Their Derivatives, R. Whistler, J. Bemiller. Academic, New York 1973; 323–337
- Rocks J. Xanthan gum. Food Technol. 1971; 25: 476–484
- Tako M., Asoto A., Nakamura S. Rheological aspects of the intermolecular interaction between xanthan and locust bean gum in aqueous media. Agric. Biol. Chem. 1984; 48: 2995–3000